A Single-Center, Open-label, Single-Arm Study to Evaluate the Effects of Repeat Doses of Subcutaneously Delivered Sumatriptan Via the Intraject System of Local Injection Site Signs in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 16 Jul 2012
At a glance
- Drugs Sumatriptan (Primary)
- Indications Migraine
- Focus Adverse reactions
- 16 Jul 2012 Additional location (USA) added as reported by ClinicalTrials.gov.
- 16 Jul 2012 Additional lead trial investigator (Patricia Chandler) identified as reported by ClinicalTrials.gov.
- 26 Mar 2008 New trial record.